Annual Drug Patent Expirations for FORTAMET
Fortamet is a drug marketed by Andrx Labs Llc and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for FORTAMET.
This drug has fifteen patent family members in nine countries.
The generic ingredient in FORTAMET is metformin hydrochloride. Two suppliers are listed for this compound. Additional details are available on the metformin hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
